Customs Today
  • Home
  • Islamabad
  • Karachi
  • Lahore
  • National
  • Transfers and Postings
  • Chambers & Associations
  • Business
No Result
View All Result
Customs Today
  • Home
  • Islamabad
  • Karachi
  • Lahore
  • National
  • Transfers and Postings
  • Chambers & Associations
  • Business
No Result
View All Result
Customs Today
No Result
View All Result
Home Karachi

Crackdown on pharma raw-material importers soon

bySohail Rab
30/09/2014
in Karachi, Latest News
Share on FacebookShare on Twitter

KARACHI: The Model Customs Collectorate Appraisement-West has planned to start a crackdown on importers of pharmaceuticals raw material, for misusing SRO551 in clearance of the material under PCT Headings 2933.5940 and 2933.5990; sources told Customs Today.

According to the Federal Board of Revenue (FBR) sources, the Appraising Intelligence Branch (AIB/R&D) of MCC-Appraisement-West has written a letter to the authorities concerned, saying that various importers on scrutiny were found involved in misusing the Serial No. 11 of SRO551(I)/2008 in clearance of “norfloxacin” under PCT Headings 2933.5940 and 2933.5990.

You might also like

Pakistan, Kazakhstan set $1b bilateral trade target, call for direct flights, regional connectivity

19/11/2026

FBR expands Customs Enforcement Indus jurisdiction to include new entry stations across three provinces

19/11/2026

In the letter, the officials also informed the collectorate that the pharmaceutical raw material by virtue of description and classification was specified in customs tariff under PCT Heading 2933.5940, chargeable to Customs Duty @20 percent thus; does not qualify for exemption from whole of sales tax under the purview of SRO551 (I)/2008, as the exemption from whole of sales tax under aforesaid SRO is available to only those pharmaceutical raw materials which are chargeable to customs duty within the extent of 10 percent.

It is pertinent to mention that the AIB has recently detected a case of misusing the SRO 551 on clearance of “Ibuprofen” imported by Stand Pharma Pakistan (Private) Limited.

Tags: AIBAppraisement-Westcrackdown on importersFederal Board of RevenueIntelligence BranchModel Customs CollectoratenorfloxacinPCTpharma raw-materialpharmaceuticals raw material

Related Stories

Pakistan, Kazakhstan set $1b bilateral trade target, call for direct flights, regional connectivity

byCT Report
19/11/2026

ISLAMABAD: Business leaders and policymakers from Pakistan and Kazakhstan have called for enhanced economic cooperation, stronger private-sector engagement and improved...

FBR expands Customs Enforcement Indus jurisdiction to include new entry stations across three provinces

byCT Report
19/11/2026

ISLAMABAD: The Federal Board of Revenue (FBR) has revised the territorial jurisdiction of the Collectorate of Customs Enforcement, Indus, bringing...

Pakistan’s Dany Group buys ex-US Consul General’s residence in Karachi for Rs. 6.92b

byCT Report
19/11/2026

KARACHI: A Pakistani business group has acquired a former United States diplomatic property in Karachi for Rs. 6.92 billion (approximately...

SBP allows banks to finance builders under new housing rules

byCT Report
19/11/2026

KARACHI: The State Bank of Pakistan (SBP) has revised its financing guidelines for builders and developers, introducing new rules aimed...

Next Post

Court grants bail to 3 TCS officials in multi-million smuggling case

  • Terms and Conditions
  • Disclaimer

© 2011 Customs Today -World's first newspaper on customs. Customs Today.

No Result
View All Result
  • Transfers and Postings
  • Latest News
  • Karachi
  • Islamabad
  • Lahore
  • National
  • Chambers & Associations
  • Business
  • About Us

© 2011 Customs Today -World's first newspaper on customs. Customs Today.